Product Code: ETC067003 | Publication Date: Jun 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
India is the world`s third largest market in terms of non-oncology precision medicine. The Indian non-oncology precision medicine market size is driven by the high prevalence of chronic diseases, increasing awareness about personalized treatments, and increasing investments from public and private entities. Additionally, government initiatives like ?Healthy India? campaign are helping to increase access to healthcare services across the country.
Increasing Prevalence of Chronic Diseases: As per WHO estimates, nearly 60% of deaths in India are due to chronic diseases such as cardiovascular disease (CVD), diabetes mellitus (DM), chronic respiratory disorders (CRD), hypertension etc., which increases demand for personalized medical care for better patient outcomes. Advances in Technology: Technological advancements in research and development have resulted in improved accuracy and speed of diagnosis with molecular diagnostics that further accelerates the uptake of non-oncology precision medicines. Similarly, advances in genomics also enable researchers to accurately predict responses to drugs based on individual genetic makeups thus facilitating personalised treatment options for patients suffering from various conditions. Government Initiatives & Investments: The Indian government has implemented several initiatives such as National Health Mission under its "Healthy India" Campaign aimed at providing better healthcare services at reduced costs or free to people living below poverty line. Furthermore, key players operating within this space have received substantial funding from both domestic investors as well as foreign investors which aids them with launching innovative products into the market quicker than before thus driving growth within this space further.
High Cost Involved ? Non-Oncology Precision Medicine can be quite expensive hence limiting its accessibility among economically weaker sections of society who cannot afford any form of sophisticated treatments available today without insurance coverages or discounts offered by hospitals/clinics, Lack Of Skilled Professionals - There is a lack skilled professionals trained specifically on new diagnostic techniques involving NOPM technologies due to inadequate training infrastructure available resulting into delayed delivery times thereby reducing overall efficiency levels, Regulatory Hurdles - Several regulatory hurdles exist when it comes down introducing novel drug therapies specific individuals tailored according their respective genetic profiles making it difficult for companies looking launch products quickly.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Non-Oncology Precision Medicine Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Non-Oncology Precision Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 India Non-Oncology Precision Medicine Market - Industry Life Cycle |
3.4 India Non-Oncology Precision Medicine Market - Porter's Five Forces |
3.5 India Non-Oncology Precision Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 India Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2021 & 2031F |
4 India Non-Oncology Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Non-Oncology Precision Medicine Market Trends |
6 India Non-Oncology Precision Medicine Market, By Types |
6.1 India Non-Oncology Precision Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 India Non-Oncology Precision Medicine Market Revenues & Volume, By Application, 2018 - 2031F |
6.1.3 India Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2018 - 2031F |
6.1.4 India Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2018 - 2031F |
6.1.5 India Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2018 - 2031F |
6.1.6 India Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2018 - 2031F |
6.1.7 India Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2018 - 2031F |
6.2 India Non-Oncology Precision Medicine Market, By Ecosystem |
6.2.1 Overview and Analysis |
6.2.2 India Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2018 - 2031F |
6.2.3 India Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2018 - 2031F |
6.2.4 India Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2018 - 2031F |
7 India Non-Oncology Precision Medicine Market Import-Export Trade Statistics |
7.1 India Non-Oncology Precision Medicine Market Export to Major Countries |
7.2 India Non-Oncology Precision Medicine Market Imports from Major Countries |
8 India Non-Oncology Precision Medicine Market Key Performance Indicators |
9 India Non-Oncology Precision Medicine Market - Opportunity Assessment |
9.1 India Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 India Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2021 & 2031F |
10 India Non-Oncology Precision Medicine Market - Competitive Landscape |
10.1 India Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2024 |
10.2 India Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |